mounjaro tirzepatide approvazione italia Mounjaro: costa 300-500 € al mese. Quando è rimborsato Mounjaro: il farmaco per il

Supplementary Data 2 (download ZIP Original pictures of cFOS and Cy5 drug appearance shown in Extended Data Fig

Key Takeaways Different FDA Approvals : Wegovy is FDA-approved specifically for chronic weight management in adults with obesity (BMI 30) or weight-related conditions (BMI 27), while Ozempic is FDA-approved only for type 2 diabetes management

Unlike pens, Zepbound vials are not eligible for insurance coverage or discounts, making them a cash-only option

Red flags requiring dose reduction or stopping: Persistent vomiting or inability to keep fluids down

Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment

The broader strategies for managing GLP-1 related constipation apply here and can meaningfully reduce secondary UTI risk